NIOSH’s evaluation of a mail-order pharmacy identifies antineoplastic agents and pharmaceutical dust exposures, including inhalation, dermal, eye, respiratory-irritant, and dermatitis concerns, and recommends ventilation and protective controls.
Source: CDC/NIOSH: HHE 2012-0044-3199 — Pharmaceutical dust exposures at a mail-order pharmacy ↗Dust entry
Antineoplastic drug dust
Airborne and settled particulate from handling hazardous or antineoplastic pharmaceutical products in pharmacy operations.
Airborne form
dust
The form describes what is suspended in air at the point of exposure. A material can produce more than one form, such as dust during handling and fume during heating.
Health effects
respiratory irritationeye irritationskin irritationdermatitisoccupational exposure to hazardous drugs
Evidence
Controls
- closed-system or contained handling
- local exhaust ventilation
- spill controls
- skin and eye protection
- exposure monitoring
- appropriate respiratory protection